National Center for Therapeutics Manufacturing

News

Military Service Members in Biopharma Manufacturing Initiative

Biopharma manufacturing companies across Texas value the same skills you’ve developed during your military career:
attention to detail, ability to follow processes, problem-solving capabilities, and teamwork to effectively and efficiently get
work done. Opportunities in this industry continue to offer growth in both scientific and nonscientific career roles.  NCTM will be offering two cohorts to military veterans and spouses.  Check out our events page for June, 2021 and December 2021 offerings.

TX Program Flier (20-247_LSED)_FINAL

Texas A&M Engineering Experiment Station to help train military service members for biomanufacturing jobs

A grant to help train military service members in Texas and North Carolina for biopharmaceutical manufacturing careers has been approved by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

The Texas A&M Engineering Experiment Station (TEES) and several educational and industry partners requested more than $400,000 for the initiative. It’s one of 14 to be funded this year by NIIMBL as part of its Project Call 3.1 program.

Dubbed Military Service Members in Biopharma Manufacturing (MSMBM), the initiative will provide targeted technical training to complement the leadership and other soft skills learned in the military. It will help prepare a minimum of 50 service members, veterans and military spouses for biopharma manufacturing jobs.

To learn more read here

UPDATE ON COVID-19 IMPACTS

Due to the ongoing uncertainty surrounding COVID-19 all classroom training and summer camps have been cancelled through the end of August. Please check back for information on fall offerings.

Optimizing Biotherapeutic Onboarding

Toward the western end of the Texas A&M campus in College Station, a modern building with clean lines—and clean rooms—houses the National Center for Therapeutics Manufacturing (NCTM). In 2008, NCTM received funding from the U.S. Health and Human Services’ Biomedical Advanced Research and Development Authority to build a vaccine-manufacturing workforce. Now, leaders at NCTM see even more ways to change the industry.

Read more from Genetic Engineering & Biotechnology News here